Continental General Insurance CO Assertio Holdings, Inc. Transaction History

Continental General Insurance CO

  • $347 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Apr 19, 2024
SELL
$1.02 - $2.57 $2.18 Million - $5.49 Million
-2,135,764 Closed
0 $0
Q3 2023

Apr 19, 2024
SELL
$2.52 - $5.69 $4.04 Million - $9.12 Million
-1,602,024 Reduced 42.86%
2,135,764 $5.46 Billion
Q2 2023

Apr 19, 2024
BUY
$5.0 - $7.66 $12.4 Million - $19 Million
2,486,751 Added 198.78%
3,737,788 $20.3 Billion
Q1 2023

Apr 19, 2024
BUY
$3.54 - $6.66 $4.43 Million - $8.33 Million
1,251,037 New
1,251,037 $7.97 Billion

Others Institutions Holding ASRT

# of Institutions
97
Shares Held
31M
Call Options Held
957K
Put Options Held
38.5K
View Full List

About Assertio Holdings, Inc.

ASRT Quotes by TradingView
  • Ticker ASRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 48,178,200
  • Market Cap $44.8M
  • Description
  • Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...
More about ASRT
Track This Portfolio

Track Continental General Insurance CO Portfolio

Follow Continental General Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continental General Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Continental General Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email